This study examined the change in plasma volume (% delta PV) in response to consecutive Wingate tests (30 sec Anaerobic Power test). Twelve active men (21 +/- 1.6 yr, 81.3 +/- 6.6 kg) performed two Wingate tests (W1 and W2, separated by 10 min) on three occasions (T1-T3, tests were two weeks apart). Exercise resistance was maintained at 75 g.kg-1 body weight during testing. Blood samples were taken immediately before (Pre) and after (IP) W1 and W2. There were no significant differences in hematocrit, hemoglobin, mean power (MP) or peak power (PP) between T1-T3. There was a marked hemoconcentration in response to W1 (IP W1, -17.4 +/- 2.6% delta PV), with a further, but not significantly greater, hemoconcentration following W2 (IP W2, -8.2 +/- 1.1% delta PV). The % delta PV, between PRE W1 and IP W2 was-20.1 +/- 3.1%. These results suggest that an existing hemoconcentration (W1) may affect the magnitude of the % delta PV response to subsequent supramaximal exercise (W2).
To examine the effect of a nutritional supplement (ATP-E) on high intensity exercise performance, 23 physically active males volunteered to perform six Wingate Anaerobic Power tests. Tests were performed prior to and at 14 and 21 days during ATP-E or placebo ingestion. The experiment followed a double-blind and random-order design. Twelve subjects (responders, R) showed an increase in preexercise blood ATP on Day 14 of ATP-E ingestion compared to control measures. The remaining 11 subjects (nonresponders, NR) had no change in preexercise blood ATP. Peak power and mean power were unchanged for both R and NR subjects across the exercise tests, but R experienced a decrease (p < 0.05) in immediate post-exercise plasma lactate on Day 14 of ATP-E testing compared to their control measures. NR had no change in peak plasma lactate at any time during the study. The results suggest that short-term high intensity exercise performance was maintained in R with less reliance on anaerobic metabolism, and that response was evident following 14 days of ATP-E ingestion.
In the present study, the effects of an increased daily dose of a dietary supplement (ATP-E, 0.2 g ··) on Wingate test performance were examined in 12 men (21 ± 1.6 years) prior to and following 14 days of supplement and placebo ingestion. A double-blind and counterbalanced design was used. Results revealed higher (p< .007) preexercise blood ATP (95.4 ± 10.5 μmol ·) for the entire group following 14 days of ATP-E ingestion compared to placebo measures (87.6 ± 10.9 μmol ·). Mean power (667 ± 73 W) was higher (p< .008) after 14 days of ATP-E ingestion versus placebo (619 ± 67 W). Peak plasma lactate was lower (p< .07) after 14 days of ATP-E ingestion (14.9 ± 2.8 mmol ·) compared to placebo (16.3 ± 1.6 mmol ·). These data suggested that the improvement in 30-s Wingate test performance in this group may be related to the increased dose of ATP-E.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.